Sengkang General Hospital is one of Singapore's public hospitals. The 1000-bed hospital opened its doors on 18 August 2018 and serves mainly the population of northeast Singapore, in particular Sengkang, Punggol, Hougang and Pasir Ris.The hospital is managed by Sengkang Health.

There are 1,000 beds in Sengkang General Hospital.

During the past decade, Sengkang General Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sengkang General Hospital" #1 sponsor was "Sengkang General Hospital" with 6 trials, followed by "Concept Medical Inc." with 4 trials sponsored, "National Cancer Centre, Singapore" with 4 trials sponsored, "Singapore General Hospital" with 4 trials sponsored and "AO Clinical Investigation and Publishing Documentation" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sengkang General Hospital" #1 collaborator was "Sengkang General Hospital" with 6 trials as a collaborator, "Duke-NUS Graduate Medical School" with 5 trials as a collaborator, "National University Hospital, Singapore" with 5 trials as a collaborator, "Changi General Hospital" with 4 trials as a collaborator and "Nanyang Technological University" with 4 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Sengkang General Hospital" are "Atherosclerosis" (4 trials), "Peripheral Artery Disease" (4 trials), "Arterial Disease of Legs" (3 trials), "Arterial Disease" (2 trials) and "Frailty" (2 trials). Many other conditions were trialed in "Sengkang General Hospital" in a lesser frequency.

Most popular intervention types in "Sengkang General Hospital" are "Device" (6 trials), "Procedure" (6 trials), "Drug" (4 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABLUMINUS DES drug eluting stent" (1 trials), "Adjuvant Atezolizumab-Bevacizumab Therapy" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sengkang General Hospital" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Sengkang General Hospital". 2 are not yet recruiting, 13 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Sengkang General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sengkang General Hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".